GoodRx is monitoring seven potential FDA drug approvals in 2025, including a possible expanded label for Ozempic.
Category: ROOT
What's next for ophthalmology?
Here are 10 new developments, breakthroughs, studies and more from the ophthalmology industry that Becker’s reported on in 2024:
SUNY Upstate asks New York Governor for $450M to build new ED
The State University of New York’s board of trustees in Albany have asked Gov. Kathy Hochul for $450 million to develop a hospital annex for Syracuse, N.Y.-based Upstate University Hospital to house a new emergency department, burn center and additiona…
Texas ASC '1st in world' to use new surgery system
Surgeon’s Point Surgery Center in Cedar Park, Texas, is the first ASC in the world to utilize Moon Surgical’s Maestro System, a digital surgical assistant.
Anti-Kickback Statute grows in scope: 5 things to know
The U.S. 2nd Court of Appeals recently revisited a whistleblower lawsuit against Novartis, a Swiss pharmaceutical company, creating a new development in the enforcement of the Anti-Kickback Statute, Policy & Medicine reported Jan. 8.
Houston Methodist hospital names president of medical staff
Christi Pramudji Dawe, MD, has been named president of the medical staff at Houston Methodist West Hospital.
Hartford HealthCare uses AI to identify critical conditions faster
Hartford (Conn.) HealthCare has partnered with Aidoc to implement artificial intelligence technology aimed at accelerating diagnoses and improving patient care.
HCA Virginia physician group inks tech partnership
Laurel, Va.-based Virginia Care Partners, an affiliate of HCA Virginia in Richmond, has established a partnership with Pearl Health, a technology platform geared specifically toward independent physician practices, IT News Online reported Jan. 8.
Where 5 ASC giants stand in 2025
Here are the most recent updates on five ASC giants as 2025 begins:
Former physician sentenced for federal opioid crime
Alexander Otellin, MD, a former physician in Charleston, W.Va., was sentenced to three years in prison followed by three years of supervised release for the unlawful distribution of oxycodone.
